BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28849339)

  • 1. Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.
    Nagata Y; Inoshita N; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Iwata T; Yoshimoto K; Yamada S
    Pituitary; 2018 Feb; 21(1):1-9. PubMed ID: 28849339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
    Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
    Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Management of Carney Complex-Associated Pituitary Pathology.
    Lonser RR; Mehta GU; Kindzelski BA; Ray-Chaudhury A; Vortmeyer AO; Dickerman R; Oldfield EH
    Neurosurgery; 2017 May; 80(5):780-786. PubMed ID: 27509071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly without imaging evidence of pituitary adenoma.
    Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
    Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
    Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
    Nishioka H; Fukuhara N; Horiguchi K; Yamada S
    J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly.
    Sarkar S; Chacko AG; Chacko G
    Acta Neurochir (Wien); 2014 Dec; 156(12):2221-30; discussion 2230. PubMed ID: 25238988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
    Taghvaei M; Sadrehosseini SM; Ardakani JB; Nakhjavani M; Zeinalizadeh M
    World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
    Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
    J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas.
    Kato M; Inoshita N; Sugiyama T; Tani Y; Shichiri M; Sano T; Yamada S; Hirata Y
    Endocr J; 2012; 59(3):221-8. PubMed ID: 22200580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 19. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma.
    Nishizawa H; Fukuoka H; Iguchi G; Inoshita N; Yamada S; Takahashi Y
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):295-9. PubMed ID: 23674160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.